Usage of antimicrobial drugs in food

Similar documents
The epidemiology of antimicrobial resistance and the link between human and veterinary medicine

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France Volumes and estimated exposure of animals to antimicrobials

Sales survey of veterinary medicinal products containing antimicrobials in France in Annual report

THE NETHERLANDS VETERINARY MEDICINES AUTHORITY

How is Ireland performing on antibiotic prescribing?

Available online at

OIE initiative establishing a global database on consumption of antimicrobials for animals: state of play

Summary of the latest data on antibiotic consumption in the European Union

Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial Animal Health

120 mln. 17 mln. The Netherlands. 12 million swine. 100 million poultry. 1,5 million dairy cows. 1 million veal calves. 1,5 million sheep and goats

HSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme

Units of measurement for animals for the collection of data per animal species: Defined Daily Dose (DDDvet) and Defined Course Dose (DCDvet)

UCD VET VIEWS CALIFORNIA CATTLEMEN S MAGAZINE JANUARY 2006 ANTIBIOTIC CHOICES FOR BEEF CATTLE

Guidance for completing the OIE template for the collection of data on antimicrobial agents intended for use in animals

Antibiotics use and Considerations: Calves and Heifers CLASSIFICATION OF CALVES. Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

Result of the OIE data collection

FACT SHEETS. On the Danish restrictions of non-therapeutical use of antibiotics for growth promotion and its consequences

Activities and achievements related to the reduction in antibiotics use and resistance in veterinary medicine in Belgium in 2016

Drug Use on the Farm & Antibiotic Resistance in Raw, Stored, & Treated Manures

Global animal production perspectives and correlated use of antimicrobial agents

DR. BASHIRU BOI KIKIMOTO

Beef Quality Assurance Program

Summary of the latest data on antibiotic consumption in the European Union

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens

The Dutch Model (of controlling antibiotic use in animals)

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

LA-MRSA in the Netherlands: the past, presence and future.

SUMMARY OF PRODUCT CHARACTERISTICS

Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves

Antibiotic Sales and Use Overview Prepared for Approvals and ACVM Group. ISBN No: (online)

Workplan on Antibiotic Usage Management

Antibiotic usage in the British sheep industry. Dr Peers Davies

Risk management of antimicrobial use and resistance from food-producing animals in Denmark

Antimicrobial use in humans

CONSUMPTION OF ANTIBIOTICS IN PUBLIC ACUTE HOSPITALS IN IRELAND DATA TO END OF 2012

The Danish risk management strategy for veterinary antimicrobial usage

Antimicrobial use in animals: OIE collection of data on antimicrobial agents used in animals (2015)

WHO perspective on antimicrobial resistance

MARAN Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2017

Use of Antibiotics in Animals. A European Perspective by a Dutch observer. Dr. Albert Meijering

BTSF. Better Training for Safer Food Initiative. Antimicrobial Resistance One Health approach MEASURE UNITS

Beef Producers. The Judicious Use of Antimicrobials for

Norwegian policies to address antimicrobial resistance

Antimicrobial consumption

COUNTRY PRESENTATION ON RECENT ACTIVITIES CARRIED OUT BY FOCAL POINT BHUTAN

European Medicines Agency role and experience on antimicrobial resistance

ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials

Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist

Global Overview on Antibiotic Use Policies in Veterinary Medicine

ANTIMICROBIAL STEWARDSHIP

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India

COUNTRY REPORT THAILAND. Sasi Jaroenpoj Department of Livestock Development

SUMMARY OF PRODUCT CHARACTERISTICS

One Analysis, One Column, Less than 9 Minutes for Over 60 Multiclass Antibiotics

European Antibiotic Awareness Day

SUMMARY OF PRODUCT CHARACTERISTICS

What is the problem? Latest data on antibiotic resistance

CONSUMPTION OF ANTIBIOTICS IN AUSTRIAN CATTLE PRODUCTION

Antimicrobial resistance (AMR): Presentation on the joint EMA/EFSA RONAFA opinion Harmonisation of SPCs of antimicrobial veterinary medicines

Human health impacts of antibiotic use in animal agriculture

Antimicrobial Use and Antimicrobial Resistance in Relation to the Canadian Pork Sector Presented by Jorge Correa Pork Committee Banff May 2013

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

DANMAP and VetStat. Monitoring resistance and antimicrobial consumption in production animals

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

SUMMARY OF PRODUCT CHARACTERISTICS. Florgane 300 mg/ml Suspension for Injection for Cattle and Pigs

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Antimicrobials. Antimicrobials

Premi Test. Art. No. R3900. R-Biopharm AG. Fast Determination of antibiotic residues in less than 4 hours

POINT PREVALENCE SURVEY A tool for antibiotic stewardship in hospitals. Koen Magerman Working group Hospital Medicine

St. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report

SUMMARY OF PRODUCT CHARACTERISTICS

UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

SUMMARY OF PRODUCT CHARACTERISTICS. Enrotron 50 mg/ml Solution for injection for cattle, pigs, dogs and cats

ESVAC (European Surveillance of Veterinary Antimicrobial Consumption)

General Directorate of Animal Health and EpizooticDiseases Control. Dr.Sabah Hassan Abdelgadir Sudan Focal Point for Veterinary products

Impact of Antimicrobial Stewardship Program

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Antimicrobial Stewardship 101

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Table 2.01 Overview of Surveillance programs in the Netherlands. available since. GP, laboratories Decentral Hospital,

Current EU Antibiotic Maximum Residue Limits

Countdown to the New Veterinary Feed Directive

SUMMARY OF PRODUCT CHARACTERISTICS

WHO efforts to reduce the impact on public and animal health of antibiotic use in animals. Dr Danilo Lo Fo Wong Senior Adviser AMR

Animal Health and Antibiotics Looking Ahead with Science

Using Antimicrobials Like We Want to Keep Them. Mike Apley, DVM, PhD Kansas State University

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

crippling production of the bacterial cell wall that protects the cell from the external environment PS

RESISTANCE, USE, INTERVENTIONS. Hugh Webb

SUMMARY OF PRODUCT CHARACTERISTICS

EMA advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials

Understanding the Veterinary Feed Directive

Transcription:

Usage of antimicrobial drugs in food producing animals In the Netherlands and some other European countries 62nd EAAP Annual Meeting, Inge van Geijlswijk, j PharmD, PhD Hospital pharmacist / director of Pharmacy faculty of Veterinary Medicine UU

Program Introduction Ways of quantifying drug use Aims of quantifying antimicrobial drug use Dutch method I: Maran method Dutch method II: under construction Prerogatives for success of an European method Take home message

CV Worked in four hospital pharmacies between 1991 and 2007; tasks amongst others therapeutic drug monitoring of anti epileptics and some antimicrobial drugs In 2007 started at the faculty of Veterinary Medicine of the Utrecht University as head of pharmacy; traditionally source of conversion data for veterinary drugs; start t coincided id d with historical i low in Dutch antimicrobial usage

Pharmaceutical Industry Sales of pharmaceuticals in 2010 in the Netherlands Drugs for human use total: m 6.000 Comprising 6% antibiotics (m 360) Veterinary drugs total: m 250 Comprising 35% antibiotics (m 87,5) (>99% for food producing animals) 15% non infectious disease related drugs (fertility and companion animals)

Research Dutch antibiotics consumption in kg 600000 overige antibiotica tetracyclines 500000 400000 300000 200000 penicillines / cefalosporines macroliden trimethoprim th i / sulfonamides aminoglycosiden fluorochinolonen hoeveelheid antibiotica (kg) 100000 veterinair 2004 veterinair 2005 veterinair 2006 veterinair 2007 extramuraal 2004 extramuraal 2005 extramuraal 2006 extramuraal 2007 intramuraal 2004 intramuraal 2005 intramuraal 2006 0 populatie

Community voorpagina Chemisch Weekblad, maart 2009

Community Human versus veterinary antimicrobial usage monitoring Human (DDD/ATC) monitoring and surveillance Related to therapeutic group and therapeutic goal; no interference of substances with different potencies, compare doxycycline (DDD=0,1g) and oxytetracycline (DDD=1g) in one therapeutic group Related to population Veterinary reports Aggregated therapeutic groups in kg, aggregation method is often unclear, eg aminoglycosids orally and parenterally in one group Relation to population is not standardised: related to meat production or life weight of livestock Diffuse and ineffective communication on this topic

Pharmaceutical Industry FIDIN sales data - FIDIN antibioticarapportage 2005, FIDIN werkgroep antibioticabeleid

Pharmaceutical Industry Substitution of oxytetracycline with doxycycline (based on usage in 2004, assuming factor 2 dosing difference) kg penicillins / cephalosporins 41040 132010 ----------- tetracyclines 264020 macrolides 22910 aminoglycosides 8580 fluoroquinolones 6880 trimethoprim / sulfonamides 93000 other 6000 ----------- 310220 total 442430-30% ------ Bron: Maran 2008

Community threats Empty pipeline of new groups of antimicrobials Environmental persistence of newer substances due to higher stability Emerging multi-resistant pathogens (MRSA, Coli and Klebsiella carrying ESBL or KPC, EHEC, VRE, clostridium difficile) Zoonoses and penetration (e.g. Q fever, MRSA carrier ship)

Knowledge transfer: sharing knowledge adds value Ways for interpretation of available data on veterinary antimicrobial consumption

Community Regulatory affairs world wide?

Research ATC (vet) Anatomical Therapeutic Chemical grouping of substances WHO defined d ATC-vet Penicillins = QJ01C or QJ51C Tetracyclins = QJ01A Doxycylin = QJ01AA02 Oxytetracyclin = QJ01AA01 Aminoglycosides = QA07A or QJ01G Gentamycin orally = QA07AA91 Gentamycin injection = QJ01GB03

Research Veterinary standardisation of antimicrobial consumption? WHO defined ATC-vet Penicillins = QJ01C Tetracyclins = QJ01A Dutch approach to veterinary DDD: 1x per day 10 mg/kg = 10 mg/kg 4x per day 10 mg/kg = 40 mg/kg 1x per week 10 mg/kg = 1,43 mg/kg

Research Available data on Dutch antimicrobial consumption The Dutch method I LEI / MARAN A sample (representative selection) of husbandries extracting specified antibiotics from the veterinarian invoices applying the nationally defined dagdoseringen for every authorized medicine in The Netherlands, per species and per kg converting the declared ed amount of medicine to treatable animal bodyweight relate to the mean present total bodyweight on the husbandry: compute mean daily doses per animal year

Research dagdoseringstabel Pharmacy faculty Veterinary Medicine

Characteristics of the MARAN method Acknowledges legal obligation in NL to apply the authorized dosages of veterinary medicines: treatable weight calculated for every single specified medicine Population data (number of animals and weights) available Still need to make choices for the exposed subgroup of animals: in diary cattle the calves are neglected, in breeding sows the mean weight of 10 piglets and 1 sow is applied

Community Daily dosages per animal year in dairy cattle Maran 2009

Community Daily dosages per animal year in sows/piglets Maran 2009

Research Available data on European antimicrobial consumption Danmap (prescription vet + hum) Svarm (prescription (since 2003) vet + hum) Norm-Normvet Normvet (sales vet + hum) Finres (sales vet) VMD-sales UK (sales vet) AFSSA-ANMV France (sales vet) Swissmedic, Swiss Agency for Therapeutic Products (sales vet) Germap (sales vet) BelVet-Sac (sales vet) FIDIN (sales vet) in kg active substance (accumulated)

Research Available data on European antimicrobial consumption Denmark the consumption is measured both in kg active substance and as a National Animal Defined Daily Dose, the latter either as the dose for one kg animal bodyweight (ADDkg) or as the dose for a defined animal body weight x (ADDx), depending on species and age group.

Research Reasons for more specified analysis Considering Potency differences between active substances Dosing differences between species??? Aim Linking usage data with resistance data Interpretation of shifts in therapy choices Anticipating future developments

Research Reasons for more specified analysis and comparison between countries Awareness stimulation! Adaptation of formularies Identifying influence of Husbandry system and management Strategic t choices National policies Knowing Populations at risk

Research Available data on European antimicrobial consumption The Dutch method II (under construction) Calculated weighed mean dose per FT group per country of all substances in a pharmacotherapeutic p group based on Dutch authorized medicines (anno 2011) of most important route of administration (mostly oral) weighed by livestock composition (kg BW of poultry*dose + kg BW veal*dose + kg BW cattle*dose + kg BW pig*dose)/total kg BW Interpretation of available kg data possible, at least some consideration of differences in potency between pharmacotherapeutic groups differences in national dosing related to livestock composition

Research Available data on European antimicrobial consumption The Dutch method II, calculated national doses mg/kg min mg/kg Max Pharmacotherapeutic group ATC vet (often UK) (often FI) Tetracyclines QJ01AA_QD06AA_QG51AA 6,69 13,65 Oral antiinfectives / ionophores QA07AA 8,04 10,20 Amphenicols QJ01BA 10,37 12,66 Trimethoprims/Sulfonamides QJ01EA / EQ / EW 20,84 28,52 β Lactams / penicillins QJ01C_QJ51C 12,94 18,21 Cephalosporins 1/2 QJ01DB / DC_QJ51RD_QJ51DA3_QG51AX 067 0,67 067 0,67 Cephalosporins 3/4 QJ01DD / DE_QJ51DA9 1,14 1,83 Aminoglycosides QJ01G 6,94 9,25 Macrolides/lincosamides QJ01FA / FF_Q QJ51FF 4,77 17,93 Quinolones QJ01MB 17,69 21,08 Fluoroquinolones QJ01MA 3,03 5,05 Combinations QJ01R_QJ51R 1,11 22,76 Other (polymyxines, pleuromutilins) QJ01AA_QD06AA_QG51AA 998 9,98 20,13

Research

Research fraction of total use (in DDD) for main therapeutic groups Dutch human vs Dutch, Belgian and Danish veterinary (2009)

Research Relationship antimicrobial use - population density

Community European method Consequent application of correct ATC vet Local identification of medicine: veterinarian or husbandry Collection of consumption data connected to species Local calculation of treatable kg Local conversion to ADD (even subgroup analysis?) for individual husbandry management purposes Report to national database ATCvet + ADD for monitoring purposes ATCvet + treatable kg + species for national calculation of ADD European collection of data Per country per species: ATCvet + treatable kg Evaluation of data Identifying risk factors for societal biological safety Imposing international i guidelines to prevent malpractices or black market for antimicrobials Creating awareness in professionals AND civilians on societal stewardship

Community European method prerogatives Consequent application of correct ATC vet Part of SPC (Summary of Product Characteristics) Collection of consumption data connected to species ADD consensus in member states of Europe, idem in SPC Report to national database National source database available for all veterinary drugs Safe environment for husbandries / veterinarians to report usage or prescription data Involvement of all parties (veterinarians, husbandry cooperations, industry) European collection of data Per country y(preferably yper species): ATCvet + treatable kg Nominator data consensus (life weight livestock) Evaluation of data Independent professionals Undisclosed publication

Community Issues to consider! Antimicrobial drugs, related to those essential for human use: 3 rd and 4 th generation cephalosporins (ceftiofur, cefquinome, cefoperazone, cefovecin) modern (2 nd generation?) fluoroquinolones (enrofloxacine, marbofloxacine, danofloxacine) colistin (?) Antibiotics with long T 1/2 or extended release formulation tulathromycine (Draxxin ) gamithromycine (Zactran ) tilmicosin (Micotil ) florfenicol (Nuflor ) oxytetracycline (several LA products) ampicilin (several LA products) (tildipiron (Zuprevo )) Essential antibiotics with extended release formulation or intrinsic long half-lifelife ceftiofur (Naxcel ) cefquinome (Cobactan LA) cefovecin (Convenia )

Nico Bondt Linda Puister (LEI Wageningen UR) Dik Mevius (CVI Wageningen UR, Lelystad / UU) contributed to data collection and interpretation p

Thank you for your attention

Utrecht University www.uu.nl